SCHEMBL3755586

SCHEMBL3755586

CCc1ccc(OP(=O)(OCl)OCl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
CYP2C19 P33261 1/20 0.58
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
POLB P06746 1/20 0.42
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
RAB9A P51151 1/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
MAPK1 P28482 1/20 0.37
BLM P54132 1/20 0.37
PLK1 P53350 1/20 0.36
MGLL Q99685 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1413702 0.88 SMN1; SMN2 (0.66) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL3758449 0.85 THRB (0.44) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL28642967 0.82 SMN1; SMN2 (0.59) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL380836 0.81 CYP2C19 (0.58) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL1958568 0.81 CYP2C19 (0.58) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL11511370 0.80 SMN1; SMN2 (0.61) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL3755582 0.80 SMN1; SMN2 (0.61) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB
SCHEMBL5852173 0.78 SMN1; SMN2 (0.70) SMN1; SMN2CYP2C19POLBRAB9AMAPT
SCHEMBL4277318 0.78 CYP3A4 (0.50) CYP3A4TSHRCA1CA2ACHE
SCHEMBL778838 0.78 SMN1; SMN2 (0.69) SMN1; SMN2CYP2C19CYP3A4TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107573375-B A kind of Memantine derivative and preparation method thereof 成都苑东生物制药股份有限公司 2019-07-26 CN disclosed
CN-107573375-A A kind of Memantine derivative and preparation method thereof 成都苑东生物制药股份有限公司 2018-01-12 CN disclosed
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2010-11-25 US disclosed
CN-101617014-A Flame-retardant adhesive composition, flexible copper-clad laminate and coverlay film SHOWA HIGHPOLYMER 2009-12-30 CN disclosed
CN-101460511-A Method for producing amino group-containing phosphate ester compound, flame-retardant resin, and flame-retardant resin composition SHOWA HIGHPOLYMER (JP) 2009-06-17 CN disclosed
EP-2036911-A1 PROCESS FOR PRODUCTION OF AMINATED PHOSPHORIC ACID ESTER COMPOUND, FLAME-RETARDANT RESIN, AND FLAME-RETARDANT RESIN COMPOSITION SHOWA HIGHPOLYMER CO., LTD. (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298506-A1 METHOD FOR PRODUCING AN AMINO GROUP-CONTAINING PHOSPHATE COMPOUND, AND A FLAME-RETARDANT RESIN AND FLAME-RETARDANT RESIN COMPOSITION ATIC, GART, RPP30 SMN1; SMN2 4067/4885CYP2C19 2840/4885CYP3A4 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.